Riley, R D; Pritchett, E L (1997) Pharmacologic management of atrial fibrillation. J Cardiovasc Electrophysiol 8:818-29
|
Hamer, M E; Wilkinson, W E; Clair, W K et al. (1995) Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol 25:984-8
|
Hamer, M E; Wilkinson, W E; McCarthy, E A et al. (1995) Heart rate during spontaneous and induced paroxysmal supraventricular tachycardia. Pacing Clin Electrophysiol 18:2155-7
|
Page, R L; Wilkinson, W E; Clair, W K et al. (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89:224-7
|
Linzer, M; Gold, D T; Pontinen, M et al. (1994) Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J Gen Intern Med 9:181-6
|
Hamer, M E; Clair, W K; Wilkinson, W E et al. (1994) Evaluation of outpatients experiencing implantable cardioverter defibrillator shocks associated with minimal symptoms. Pacing Clin Electrophysiol 17:938-43
|
Hamer, M E; Blumenthal, J A; McCarthy, E A et al. (1994) Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. Am J Cardiol 74:826-9
|
Clair, W K; Wilkinson, W E; McCarthy, E A et al. (1993) Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients. Circulation 87:1114-22
|
Pritchett, E L; Wilkinson, W E; Clair, W K et al. (1993) Comparison of mortality in patients treated with propafenone to those treated with a variety of antiarrhythmic drugs for supraventricular arrhythmias. Am J Cardiol 72:108-10
|
Pritchett, E L (1992) Management of atrial fibrillation. N Engl J Med 326:1264-71
|
Showing the most recent 10 out of 16 publications